It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2012.
2012 | Bangalore, Karnataka, India | Struck OffPharx Pharmaceuticals Private Limited, a struck off private limited company, was established on 16 August 2012 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24233KA2012PTC065387. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Rachan Hanbal (Director), Srinath Hosur Nanjundareddy (Director), Harish Kumar Narayanaswamy Venkatagirikote (Director). Past directors included Madhusudan Venkatesh. Its latest AGM occurred on 29 September 2017, with the balance sheet filed on 31 March 2017. It is based at #71/2, Jaraganahalli, Kanakapura Main Road J.P. Nagar 6Th Phase, Near S.M. Kalyana, Mantapa,, Bangalore, Karnataka, 560078.
U24233KA2012PTC065387
065387
16 August 2012
₹1.00 M
₹1.00 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Pharx Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rachan Hanbal | Director | 05 Nov 2020 | Current |
| Srinath Hosur Nanjundareddy | Director | 16 Aug 2012 | Current |
| Harish Kumar Narayanaswamy Venkatagirikote | Director | 20 Jan 2014 | Current |
| Rameshbabu Chandrappa | Director | 20 Jan 2014 | Current |
| Hosur Venkata Reddy Srinivasa Reddy | Director | 16 Aug 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Jan 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharx Pharmaceuticals Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 5.02% increase. The company also saw a substantial fall in profitability, with a 27.48% decrease in profit. The company's net worth moved up by a moderate rise of 5.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Pharx Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pharx Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pharx Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharx Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rachan Hanbal was appointed as a Director was appointed as a Director on 05 Nov 2020 & has been associated with this company since 5 years 1 month . was completed.
Progress on Pharx Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records. was documented.
Progress on Pharx Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Bangalore. was documented.
The activity Harish Kumar Narayanaswamy Venkatagirikote was appointed as a Director was appointed as a Director on 20 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
The activity Rameshbabu Chandrappa was appointed as a Director was appointed as a Director on 20 Jan 2014 & has been associated with this company since 11 years 11 months . was completed.
The activity Srinath Hosur Nanjundareddy was appointed as a Director was appointed as a Director on 16 Aug 2012 & has been associated with this company since 13 years 4 months . was completed.
The CIN of Pharx Pharmaceuticals Private Limited is U24233KA2012PTC065387.
Pharx Pharmaceuticals Private Limited is headquartered at #71/2, Jaraganahalli, Kanakapura Main Road J.P. Nagar 6Th Phase, Near S.M. Kalyana, Mantapa,, Bangalore, Karnataka, 560078.
Pharx Pharmaceuticals Private Limited was incorporated on 16 August 2012.
The current directors of Pharx Pharmaceuticals Private Limited are
The primary industry of Pharx Pharmaceuticals Private Limited is Pharma.
Pharx Pharmaceuticals Private Limited is unlisted.
The authorized capital of Pharx Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Pharx Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX